Show simple item record

dc.contributor.authorRimstad, Espen
dc.contributor.authorAndersen, Lene Frost
dc.contributor.authorFrølich, Wenche
dc.contributor.authorFrøyland, Livar
dc.contributor.authorHalvorsen, Ragnhild
dc.contributor.authorHøiby, Ernst Arne
dc.contributor.authorKapperud, Georg
dc.contributor.authorLunestad, Bjørn Tore
dc.contributor.authorLassen, Jørgen Fredrik
dc.contributor.authorMeltzer, Helle Margrete
dc.contributor.authorNarvhus, Judith Ann
dc.contributor.authorNygård, Karin
dc.contributor.authorNesbakken, Truls
dc.contributor.authorOlsvik, Ørjan
dc.contributor.authorPaulsen, Jan Erik
dc.contributor.authorRobertson, Lucy Jane
dc.contributor.authorTranulis, Michael A.
dc.contributor.authorTryland, Morten
dc.contributor.authorVainio, Kirsti
dc.contributor.authorHaugen, Margaretha
dc.date.accessioned2020-09-10T10:25:14Z
dc.date.available2020-09-10T10:25:14Z
dc.date.issued2007-06-15
dc.description.abstractOn 10. March 2006 , The Norwegian Food Safety Authority (Mattilsynet) decided that, on the basis of VKM’s previous risk assessment (2005), Nutramigen 1 with Lactobacillus rhamnosus GG (LGG) could not be marketed in Norway as medical foods for infants (0-4 months). In addition, The Norwegian Food Safety Authority (Mattilsynet) decided (08. November 2006) to withdraw permission for marketing ofNutramigen 2 with LGG, which is a milk supplement for infants aged between 4 and 6 months, with cow’s milk and soy protein allergy. On 13. December 2006, Mead Johnson Nutritionals appealed against this decision from The Norwegian Food SafetyAuthority (Mattilsynet). The Norwegian Food Safety Authority forwarded the appeal from the companies, asked the VKM Panel on biological hazards and the VKM Panel on nutrition, dietetic products, novel food and allergy, for a new risk assessment including the new data provided in the appeal.en_US
dc.description.abstractBasert på VKMs tidligere risikovurdering fra 2005, bestemte Mattilsynet 10. mars 2006 atNutramigen 1 med LGG ikke kunne markedsføres som næringsmiddel til spesielle medisinske formål (0-4 måneder) i Norge. I tillegg trakk Mattilsynet tilbake tillatelsen (08. november, 2006) til å markedsføre Nutramigen 2 med LGG, som er en melkeerstatning for spedbarn mellom fire og seks måneder som er allergiske mot kumelk og soyaproteiner. Den 13. desember 2006 Mead Johnson Nutritionals på vedtaket fra Mattilsynet. Mattilsynet videresendte klagen fra selskapene og ba VKMs faggrupper for hygiene og smittestoffer samt ernæring, dietetiske produkter, ny mat og allergi om å foreta en ny risikovurdering basert på nye data som er lagt frem i forbindelse med klagen.en_US
dc.descriptionSource at <a href=https://vkm.no/>https://vkm.no/</a>en_US
dc.identifier.citationRimstad E, Andersen LF, Frølich W, Frøyland L, Halvorsen R, Høiby EA, Kapperud G, Lunestad BT, Lassen JF, Meltzer HM, Narvhus J, Nygård K, Nesbakken T, Olsvik Ø, Paulsen JE, Robertson LJ, Tranulis M, Tryland M, Vainio K, Haugen M. Risk assessment on use of Lactobacillus rhamnosus (LGG) as an ingredient in infant formula and baby foods (II) . Norwegian Scientific Committee for Food Safety (VKM); 2007. 32 p.. VKM Report(2007:38)en_US
dc.identifier.cristinIDFRIDAID 1533160
dc.identifier.urihttps://hdl.handle.net/10037/19301
dc.language.isoengen_US
dc.relation.ispartofseriesVKM Report ; 2007:38en_US
dc.relation.urihttps://vkm.no/download/18.13735ab315cffecbb51fb56/1501077416972/63bb45d3eb.pdf
dc.rights.accessRightsopenAccessen_US
dc.subjectVDP::Medical disciplines: 700::Health sciences: 800en_US
dc.subjectVDP::Medisinske Fag: 700::Helsefag: 800en_US
dc.titleRisk assessment on use of Lactobacillus rhamnosus (LGG) as an ingredient in infant formula and baby foods (II)en_US
dc.typeResearch reporten_US
dc.typeForskningsrapporten_US


File(s) in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record